Comprehensive analysis of the correlation between base‑excision repair gene SNPs and esophageal squamous cell carcinoma risk in a Chinese Han population

Pu,Yu; Zhao,Liang; Dai,Nan; Xu,Mingfang

doi:10.3892/mco.2020.2066

Comprehensive analysis of the correlation between base‑excision repair gene SNPs and esophageal squamous cell carcinoma risk in a Chinese Han population

Authors:
- Yu Pu
- Liang Zhao
- Nan Dai
- Mingfang Xu
View Affiliations

Affiliations: Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, P.R. China
Published online on: June 9, 2020 https://doi.org/10.3892/mco.2020.2066
Pages: 228-236

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study sought to assess the relationship between single nucleotide polymorphisms (SNPs) affecting DNA base‑excision repair (BER) genes and esophageal squamous cell carcinoma (ESCC) risk in a Han Chinese population. Genes screened for such SNPs included 8‑oxoguanine DNA glycosylase (OGG1), apurinic/apyrimidinic endonuclease 1 (APE1) and X‑ray repair cross‑complementing group 1 protein (XRCC1). Blood samples that had been collected in a prospective manner were used for DNA extraction, with all DNA samples then being subjected to PCR‑restriction fragment length polymorphism genotyping for BER gene SNPs, including APE1 Asp148Glu and ‑141T/G, OGG1 Ser326Cys, and XRCC1 Arg399Gln. The relationship between these SNPs and ESCC risk was then assessed, with the comparability of the case and control groups being enhanced via propensity score matching (PSM). This study initially included 642 healthy controls and 321 ESCC patients, with PSM optimization leading to a final analyzed total of 311 matched subjects per group (311 total). Factors associated with elevated ESCC risk in this analysis included advanced age, being male and smoking. We further identified that the XRCC1 399 Gln/Gln genotype was associated with a significant reduction in ESCC risk prior to propensity matching (odds ratio=0.48; 95% CI: 0.23‑1.00; P<0.05), although this did not remain true following matching. For the remaining analyzed SNPs, no significant associations between genotype and ESCC risk were detected prior to or following propensity matching. A multivariate analysis incorporating patient age, sex, smoking status and drinking status failed to detect any relationship between the four tested genotypes and ESCC risk. In conclusion, being male, a smoker or of advanced age was associated with an elevated ESCC risk. However, we did not detect any significant relationship between ESCC risk and BER polymorphisms in XRCC1, OGG1, APE1 or the APE1 promoter region in a Han Chinese population.

View Figures

View References

1	Liu B, Cheng B, Wang C, Chen P and Cheng Y: The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma. Sci Rep. 8(10101)2018.PubMed/NCBI View Article : Google Scholar
2	Zhang ZY, Xuan Y, Jin XY, Tian X and Wu R: Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population. Genet Mol Res. 12:2567–2577. 2013.PubMed/NCBI View Article : Google Scholar
3	Yin M, Tan D and Wei Q: Genetic variants of the XRCC1 gene and susceptibility to esophageal cancer: A meta-analysis. Int J Clin Exp Med. 2:26–35. 2009.PubMed/NCBI
4	Bosetti C, La Vecchia C, Talamini R, Simonato L, Zambon P, Negri E, Trichopoulos D, Lagiou P, Bardini R and Franceschi S: Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer. 87:289–294. 2000.PubMed/NCBI
5	Talamini G, Capelli P, Zamboni G, Mastromauro M, Pasetto M, Castagnini A, Angelini G, Bassi C and Scarpa A: Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer. 86:874–878. 2000.PubMed/NCBI View Article : Google Scholar
6	Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, et al: Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 64:4378–4384. 2004.PubMed/NCBI View Article : Google Scholar
7	Li WQ, Hu N, Hyland PL, Gao Y, Wang ZM, Yu K, Su H, Wang CY, Wang LM, Chanock SJ, et al: Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis. 34:1536–1542. 2013.PubMed/NCBI View Article : Google Scholar
8	Yang X, Zhu H, Qin Q, Yang Y, Yang Y, Cheng H and Sun X: Genetic variants and risk of esophageal squamous cell carcinoma: A GWAS-based pathway analysis. Gene. 556:149–152. 2015.PubMed/NCBI View Article : Google Scholar
9	Wang Z, Gan L, Nie W and Geng Y: The OGG1 Ser326Cys polymorphism and the risk of esophageal cancer: A meta-analysis. Genet Test Mol Biomarkers. 17:780–785. 2013.PubMed/NCBI View Article : Google Scholar
10	Dai ZJ, Shao YP, Kang HF, Tang W, Xu D, Zhao Y, Liu D, Wang M, Yang PT and Wang XJ: Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis. World J Gastroenterol. 21:5081–5089. 2015.PubMed/NCBI View Article : Google Scholar
11	Li S, Deng Y, You JP, Chen ZP, Peng QL, Huang XM, Lu QH, Huang XL, Zhao JM and Qin X: XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: A meta-analysis. Dig Dis Sci. 58:1880–1890. 2013.PubMed/NCBI View Article : Google Scholar
12	Dai L, Wang K, Zhang J, Lv Q, Wu X and Wang Y: XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies. Int J Cancer. 125:1102–1109. 2009.PubMed/NCBI View Article : Google Scholar
13	Yun YX, Dai LP, Wang P, Wang KJ, Zhang JY and Xie W: Association of polymorphisms in X-ray repair cross complementing 1 gene and risk of esophageal squamous cell carcinoma in a Chinese population. Biomed Res Int. 2015(509215)2015.PubMed/NCBI View Article : Google Scholar
14	Upadhyay R, Malik MA, Zargar SA and Mittal B: OGG1 Ser326Cys polymorphism and susceptibility to esophageal cancer in low and high at-risk populations of Northern India. J Gastrointest Cancer. 41:110–115. 2010.PubMed/NCBI View Article : Google Scholar
15	Tse D, Zhai R, Zhou W, Heist RS, Asomaning K, Su L, Lynch TJ, Wain JC, Christiani DC and Liu G: Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control. 19:1077–1083. 2008.PubMed/NCBI View Article : Google Scholar
16	Liu GC, Zhou YF, Su XC and Zhang J: Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: A case control study. BMC Cancer. 19(24)2019.PubMed/NCBI View Article : Google Scholar
17	Nanda SS, Gandhi AK, Rastogi M, Khurana R, Hadi R, Sahni K, Mishra SP, Srivastava AK, Bhatt MLB and Parmar D: Evaluation of XRCC1 gene polymorphism as a biomarker in head and neck cancer patients undergoing chemoradiation therapy. Int J Radiat Oncol Biol Phys. 101:593–601. 2018.PubMed/NCBI View Article : Google Scholar
18	Liu R, Yin LH and Pu YP: Reduced expression of human DNA repair genes in esophageal squamous-cell carcinoma in china. J Toxicol Environ Health A. 70:956–963. 2007.PubMed/NCBI View Article : Google Scholar
19	Cai L, You NC, Lu H, Mu LN, Lu QY, Yu SZ, Le AD, Marshall J, Heber D and Zhang ZF: Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer. 106:2345–2354. 2006.PubMed/NCBI View Article : Google Scholar
20	Li M, Yu X, Zhang ZY, Wu CL and Xu HL: Interaction of XRCC1 Arg399Gln polymorphism and alcohol consumption influences susceptibility of esophageal cancer. Gastroenterol Res Pract. 2016(9495417)2016.PubMed/NCBI View Article : Google Scholar
21	Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA and Khussainova EM: The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 4(70)2013.PubMed/NCBI View Article : Google Scholar
22	Hamajima N, Saito T, Matsuo K and Tajima K: Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers. J Mol Diagn. 4:103–107. 2002.PubMed/NCBI View Article : Google Scholar
23	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
24	Yin J, Vogel U, Ma Y, Qi R and Wang H: Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. Mutat Res. 641:12–18. 2008.PubMed/NCBI View Article : Google Scholar
25	Xing D, Qi J, Miao X, Lu W, Tan W and Lin D: Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer. 100:600–605. 2002.PubMed/NCBI View Article : Google Scholar
26	Xiong Y, Zhang Q, Ye J, Pan S and Ge L: Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies. PLoS One. 13(e0206853)2018.PubMed/NCBI View Article : Google Scholar
27	Pan JL, Gao J, Hou JH, Hu DZ and Li L: Interaction between environmental risk factors and catechol-O-methyltransferase (COMT) and X-Ray repair cross-complementing protein 1 (XRCC1) gene polymorphisms in risk of lung cancer among non-smoking Chinese women: A case-control study. Med Sci Monit. 24:5689–5697. 2018.PubMed/NCBI View Article : Google Scholar
28	Lin J, Ye Q, Wang Y, Wang Y and Zeng Y: Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis. Medicine (Baltimore). 97(e11852)2018.PubMed/NCBI View Article : Google Scholar
29	Bashir K, Sarwar R, Fatima S, Saeed S, Mahjabeen I and Akhtar Kayani M: Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma. J BUON. 23:234–243. 2018.PubMed/NCBI
30	Feki-Tounsi M, Khlifi R, Louati I, Fourati M, Mhiri MN, Hamza-Chaffai A and Rebai A: Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population. Environ Sci Pollut Res Int. 24:22476–22484. 2017.PubMed/NCBI View Article : Google Scholar
31	Fouad H, Sabry D, Morsi H, Shehab H and Abuzaid NF: XRCC1 Gene polymorphisms and miR-21 expression in patients with colorectal carcinoma. Eurasian J Med. 49:132–136. 2017.PubMed/NCBI View Article : Google Scholar
32	Chen S, Zhu XC, Liu YL, Wang C and Zhang KG: Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer. Genet Mol Res. 15:2016.PubMed/NCBI View Article : Google Scholar
33	Zhai XD, Mo YN, Xue XQ, Zhao GS, Gao LB, Ai HW and Ye Y: XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population. Bull Cancer. 96:E61–E65. 2009.PubMed/NCBI View Article : Google Scholar
34	Moser J, Kool H, Giakzidis I, Caldecott K, Mullenders LH and Fousteri MI: Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner. Mol Cell. 27:311–323. 2007.PubMed/NCBI View Article : Google Scholar
35	Tomkinson AE, Naila T and Khattri Bhandari S: Altered DNA ligase activity in human disease. Mutagenesis. 35:51–60. 2020.PubMed/NCBI View Article : Google Scholar
36	Wang R, Hao W, Pan L, Boldogh I and Ba X: The roles of base excision repair enzyme OGG1 in gene expression. Cell Mol Life Sci. 75:3741–3750. 2018.PubMed/NCBI View Article : Google Scholar
37	Ba X and Boldogh I: 8-Oxoguanine DNA glycosylase 1: Beyond repair of the oxidatively modified base lesions. Redox Biol. 14:669–678. 2018.PubMed/NCBI View Article : Google Scholar
38	Fleming AM and Burrows CJ: 8-Oxo-7,8-dihydroguanine, friend and foe: Epigenetic-like regulator versus initiator of mutagenesis. DNA Repair (Amst). 56:75–83. 2017.PubMed/NCBI View Article : Google Scholar
39	Wei B, Zhou Y, Xu Z, Xi B, Cheng H, Ruan J, Zhu M, Hu Q, Wang Q, Wang Z, et al: The effect of hOGG1 Ser326Cys polymorphism on cancer risk: Evidence from a meta-analysis. PLoS One. 6(e27545)2011.PubMed/NCBI View Article : Google Scholar
40	Zou H, Li Q, Xia W, Liu Y, Wei X and Wang D: Association between the OGG1 Ser326Cys polymorphism and cancer risk: Evidence from 152 case-control studies. J Cancer. 7:1273–1280. 2016.PubMed/NCBI View Article : Google Scholar
41	Peng Q, Lu Y, Lao X, Chen Z, Li R, Sui J, Qin X and Li S: Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: A meta-analysis. Diagn Pathol. 9(108)2014.PubMed/NCBI View Article : Google Scholar
42	Li M and Wilson DM III: Human apurinic/apyrimidinic endonuclease 1. Antioxid Redox Signal. 20:678–707. 2014.PubMed/NCBI View Article : Google Scholar
43	Dai ZJ, Wang XJ, Kang AJ, Ma XB, Min WL, Lin S, Zhao Y, Yang PT, Wang M and Kang HF: Association between APE1 single nucleotide polymorphism (rs1760944) and cancer risk: A meta-analysis based on 6,419 cancer cases and 6,781 case-free controls. J Cancer. 5:253–259. 2014.PubMed/NCBI View Article : Google Scholar
44	Zhou B, Shan H, Su Y, Xia K, Shao X, Mao W and Shao Q: The association of APE1-656T>G and 1349 T>G polymorphisms and cancer risk: A meta-analysis based on 37 case-control studies. BMC Cancer. 11(521)2011.PubMed/NCBI View Article : Google Scholar
45	Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY and Shi R: Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: A meta-analysis of 18 case-control studies. Onco Targets Ther. 9:1499–1510. 2016.PubMed/NCBI View Article : Google Scholar
46	Li H, Zou J, Mi J, Wei X, Zhao D, Zhang S and Tian G: Association of APE1 Gene Asp148Glu variant with digestive cancer: A meta-analysis. Med Sci Monit. 21:2456–2466. 2015.PubMed/NCBI View Article : Google Scholar